MAManya Angley

Manya Angley

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Manya Angley has a total of 60 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Proportion of patients admitted to rural and remote hospitals that experience a 30-day medication-related readmission: a retrospective cohort study

    by Kingston Yeung, Gi Kon Nam, Klaudia Englezos, Aagam Bordia, Stephen Carter, Rebekah Moles, Hana Amer, Manya Angley, Charley Budgeon, Brett Chambers, et al.

    Introduction: Medication-related readmissions are a significant and preventable cause of patient harm. Patients living in rural and remote areas may face inequitable access to healthcare and fragmented continuity of care, increasing their vulnerability to medication-related harm. Despite this, the burden and drivers of medication-related readmissions in these settings remain poorly understood. Determining the current burden and identifying factors associated with medication-related readmissions is essential to inform targeted strategies to improve medication safety. Aim: To determine the proportion of adult patients with a medication-related readmission within 30 days of discharge from rural and remote hospitals, and to identify factors potentially associated with these readmissions. Method: A retrospective cohort study was conducted using medical records of adults admitted to rural and remote hospitals in New South Wales, Australia, between June 1, 2022 and August 31, 2023. Readmissions within 30 days were assessed for medication-related causes using the AT-HARM10, a validated 10-item tool based on admission notes, medication lists, inpatient pathology results, and discharge summaries. Patient demographics, comorbidities and admission details were extracted. Comorbidity burden was calculated using the Charlson Comorbidity Index (CCI). Medication lists were based on medications charted 12 h before discharge. Univariable logistic regression was performed to explore factors associated with 30-day medication-related readmissions, with results reported as unadjusted odds ratios (uOR). Results: Of the 2220 patients admitted during the study period, 6% (n = 133) experienced a 30-day readmission, of which 22.5% (n = 30) were medication-related. Overall, 1.4% of all admitted patients experienced a 30-day medication-related readmission. Older age (uOR 1.04; 95% CI 1.01–1.07), higher CCI (uOR 1.22; 95% CI 1.04–1.44), a greater number of regular medications (uOR 1.07 per additional medication; 95% CI 1.01–1.14), and insulin use (uOR 2.80; 95% CI 1.06–7.42) were associated with medication-related readmission. Conclusion: In rural and remote hospitals, a small but clinically important proportion of patients experienced a medication-related readmission within 30 days of discharge. Unadjusted analysis identified that older age, multimorbidity, polypharmacy and insulin use were associated with increased risk. Larger studies are needed to validate these findings and evaluate strategies to reduce medication-related harm in rural and remote populations.

  • Open Access

    Medication Management Strategies at Hospital Admission: A Systematic Review and Meta‐Analysis

    by Tara Emadi, Chin Hang Yiu, Shania Liu, Dihan Tang, Kingston Yeung, Melissa Baysari, Charley Budgeon, Stephen Carter, Deirdre Criddle, Cristen Fleming, et al.

    Hospital admission is high risk for medication harm due to transfer errors, delays, and charting mistakes. Up to 70% of admission medication lists contain errors, 59% potentially harmful, highlighting the need for safety strategies. The aim of the study is to systematically review the effectiveness of strategies for medication management at hospital admission. Following PRISMA guideline, three databases were searched for RCTs. Subgroup analyses assessed outcomes including mortality, readmissions/Emergency Department (ED) visits, length of stay (LOS), medication errors, and adverse drug events (ADEs), with meta‐analysis where possible. Nineteen RCTs were included. The strategies were classified into five categories: medication reconciliation, supported medication review, collaborative model of medication review, Partnered Pharmacist Medication Charting (PPMC), and real‐time health information exchange (HIE) tools. Medication reconciliation alone showed limited effectiveness in reducing medication errors and ADEs while combining with other strategies was more effective in minimizing ADEs. The meta‐analysis showed that PPMC can be considered a potential strategy to reduce medication errors and ADEs. Outcomes such as readmission, ED visits, mortality, and LOS were reported as secondary outcomes, and the strategies showed no significant effect in improving them. Overall admission strategies can reduce medication‐related outcomes such as medication errors and ADEs; however, stronger evidence is needed to confirm their impact on other outcomes. Future research should focus on integrating Clinical Decision Support (CDS) and stratification tools into electronic medical records to enhance the efficiency of these tools.


  • Open Access

    Editorial: Achieving safe medication management during transitions of care from hospital: time for a stewardship approach

    by Rohan A Elliott, Manya Angley, Deirdre T Criddle, Fatemeh Emadi, Shania Liu, Jonathan Penm

    An interdisciplinary stewardship approach is proposed to address the intractable problem of medication errors and harms following hospital discharge.


  • Hospital‐initiated post‐discharge medication reviews in Australia: expert opinion on the barriers and enablers to implementation

    by Manya Angley, Deirdre Criddle, Deborah Rigby, Rohan A. Elliott, Katie Phillips, Jonathan Penm, Janet K. Sluggett, Joy Gailer, Horst Thiele, Amy T. Page, et al.

    Medication‐related harm can occur during transitions of care. Revised Home Medicines Review (HMR) and Residential Medication Management Review (RMMR) program rules were published in April 2020 which allowed provision for some hospital medical practitioners to refer at‐risk patients for medication review. In turn, the Society of Hospital Pharmacists of Australia's (SHPA's) Transitions of Care and Primary Care Leadership Committee developed a framework to support hospitals facilitating Hospital‐Initiated Medication Reviews (HIMRs) via three pathways: HMR, RMMR, and Hospital Outreach Medication Review. Following the compilation of draft barriers and enablers to implementation of the SHPA HIMR framework, refinement occurred after broad consultation with hospital‐ and primary care‐based pharmacists with transitions of care experience. The finalised list of barriers and enablers can inform broadscale implementation of the SHPA HIMR framework to reduce medication‐related harm when high‐risk patients transition from hospital to primary care and aged care.


  • Open Access

    Simplifying Medication Regimens for People Receiving Community-Based Home Care Services: Outcomes of a Non-Randomized Pilot and Feasibility Study

    by Janet K Sluggett, Choon Ean Ooi, Stephanie Gibson, Manya T Angley, Megan Corlis, Michelle E Hogan, Tessa Caporale, Georgina A Hughes, Jan Van Emden, J Simon Bell

    Purpose: Being able to manage a complex medication regimen is key to older people continuing to live at home. This study determined the feasibility of a multi-component intervention to simplify medication regimens for people receiving community-based home care services. Patients and Methods: Research nurses recruited people receiving community-based home care services to participate in this non-randomized pilot and feasibility study (Australian New Zealand Clinical Trials Registry ACTRN12618001130257). Participants received a one-off clinical pharmacist intervention comprising medication reconciliation, assessment of capacity to self-manage medications, and application of a structured 5-step tool to identify medication simplification opportunities. A mixed-methods feasibility assessment with an explanatory design was undertaken to assess recruitment, protocol adherence and stakeholder acceptability. Data from interviews with 12 stakeholders were thematically analyzed. Secondary outcome measures, including medication discrepancies, and changes in number of medication administration times per day, quality of life, medication adherence and health service utilization, were determined over a 4-month follow-up. Results: Twenty-five out of the target 50 participants were recruited. Initial recruitment was impacted by apparent uncertain role responsibilities in medication management, with some clients who declined to participate perceiving they would be unlikely to benefit or being reluctant to change regimens. However, with few exceptions, participants who received intervention did so with a high degree of protocol adherence and acceptability. Stakeholders valued the intervention and supported wider implementation. Discrepancies between the baseline medication history from the general medical practitioner and the pharmacist-compiled “best possible medication history” were identified for all participants’ regimens (median of 6 per participant), with one-third resolved at follow-up. Simplification was possible for 14 participants (56%) and implemented for 7 (50%) at follow-up. No significant changes in other secondary outcomes were observed. Conclusion: The intervention was delivered as planned, and valued by stakeholders. Recruitment barriers should be addressed before wider implementation.